Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

Large Molecule Specific Assay Operation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team

(2013) Lauren Stevenson et al.   AAPS Journal

Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis

(2013) Lenka Fialová et al.   JOURNAL OF NEUROIMMUNOLOGY

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

(2013) F. Puentes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Autoantibodies to Nervous System-Specific Proteins Are Elevated in Sera of Flight Crew Members: Biomarkers for Nervous System Injury

(2013) Mohamed B. Abou-Donia et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

 -Synuclein in CSF of patients with severe traumatic brain injury

(2013) S. Mondello et al.   NEUROLOGY

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

(2012) R. Tortelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis

(2012) K. B. Boylan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALS

(2012) Ching-Hua Lu et al.   PLoS One

In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study

(2011) Axel Petzold et al.   BRAIN

Factors affecting the diagnostic delay in amyotrophic lateral sclerosis

(2011) Eleonora Cellura et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS

(2011) Jeban Ganesalingam et al.   JOURNAL OF NEUROCHEMISTRY

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

(2011) A. Chio et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evidence for acute neurotoxicity after chemotherapy

(2010) Axel Petzold et al.   ANNALS OF NEUROLOGY

A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect

(2010) Ching-Hua Lu et al.   JOURNAL OF NEUROSCIENCE METHODS

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis

(2010) Martin R. Turner et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Prognostic factors in ALS: A critical review

(2009) Adriano Chiò et al.   Amyotrophic Lateral Sclerosis

Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis

(2009) L. Fialová et al.   EUROPEAN JOURNAL OF NEUROLOGY

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

(2009) Kevin Boylan et al.   JOURNAL OF NEUROCHEMISTRY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis

(2008) Mamede De Carvalho et al.   Amyotrophic Lateral Sclerosis